[Dimethyl suberimidate as a specific inductor of apoptosis in transformed cells]

Tsitologiia. 2001;43(8):747-54.
[Article in Russian]

Abstract

A modification of protein-protein interactions can be considered to be a way to regulate cell death. Chemical cross-linking agents have been traditionally used for protein complexing. This study has been undertaken to test a possibility to induce and(or) to modify cell death by a homobifunctional cross-linker dimethyl suberimidate (DMS). It was shown that the protein cross-linking by DMS resulted in a death of transformed cells by apoptosis. DMS-induced apoptosis was accompanied by cell cycle perturbations and down-regulation of p21/Waf1 mRNA expression. The RT-PCR analysis of bcl-2 family genes revealed the engagement of mitochondria in DMS-induced cytotoxicity. Then, the influence of DMS treatment on TNF-dependent and Fas-mediated apoptosis was investigated. Cell pre-incubation with DMS resulted in their increasing sensitivity for the TNF cytotoxic effect, though activities of anti-Fas cytotoxic antibodies were inhibited. The effects observed are probably due to cross-linking of TNF-receptors. Thus, this study first demonstrated that a chemical cross-linker DMS in capable of inducing apoptosis in transformed cells and modifying TNF-dependent and Fas-mediated apoptosis.

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Apoptosis / genetics
  • Cell Line, Transformed
  • Cross-Linking Reagents / pharmacology*
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins / drug effects
  • Cyclins / genetics
  • Dimethyl Suberimidate / pharmacology*
  • Gene Expression Regulation / drug effects
  • Genes, bcl-2 / drug effects
  • Humans
  • Mice
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha / pharmacology
  • fas Receptor / genetics

Substances

  • CDKN1A protein, human
  • Cdkn1a protein, mouse
  • Cross-Linking Reagents
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • Tumor Necrosis Factor-alpha
  • fas Receptor
  • Dimethyl Suberimidate